LXRX vs. SPY
Compare and contrast key facts about Lexicon Pharmaceuticals, Inc. (LXRX) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LXRX or SPY.
Correlation
The correlation between LXRX and SPY is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
LXRX vs. SPY - Performance Comparison
Key characteristics
LXRX:
-0.36
SPY:
2.17
LXRX:
0.10
SPY:
2.88
LXRX:
1.01
SPY:
1.40
LXRX:
-0.37
SPY:
3.26
LXRX:
-0.72
SPY:
14.09
LXRX:
51.50%
SPY:
1.95%
LXRX:
102.49%
SPY:
12.64%
LXRX:
-99.80%
SPY:
-55.19%
LXRX:
-99.72%
SPY:
-2.83%
Returns By Period
In the year-to-date period, LXRX achieves a 25.92% return, which is significantly higher than SPY's 0.44% return. Over the past 10 years, LXRX has underperformed SPY with an annualized return of -17.77%, while SPY has yielded a comparatively higher 13.15% annualized return.
LXRX
25.92%
31.88%
-41.88%
-39.22%
-25.71%
-17.77%
SPY
0.44%
-2.83%
6.59%
25.62%
14.26%
13.15%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
LXRX vs. SPY — Risk-Adjusted Performance Rank
LXRX
SPY
LXRX vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Lexicon Pharmaceuticals, Inc. (LXRX) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
LXRX vs. SPY - Dividend Comparison
LXRX has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.20%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LXRX Lexicon Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.20% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
LXRX vs. SPY - Drawdown Comparison
The maximum LXRX drawdown since its inception was -99.80%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for LXRX and SPY. For additional features, visit the drawdowns tool.
Volatility
LXRX vs. SPY - Volatility Comparison
Lexicon Pharmaceuticals, Inc. (LXRX) has a higher volatility of 36.12% compared to SPDR S&P 500 ETF (SPY) at 4.49%. This indicates that LXRX's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.